CClinicalTrials.gg
CompletedNCT06290973Updated Mar 4, 2024

Quality of Life and Health Perception After Surgery of Varicose Veins

An observational study in Quality of Life and Varicose Veins, sponsored by Hospital Clínico Universitario de Valladolid. Completed at 1 site in Spain. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-03-04.

Sponsored by Hospital Clínico Universitario de Valladolid · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
58
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The aim of this study is to analyze changes in health perception and quality of life in patients after surgery for varicose veins using clinical score VCSS and QoL scores SF12 as general health questionary and Veines QoL/Sym as disease specific questionary.

02

Conditions studied

  • Quality of Life
  • Varicose Veins

Browse trials for

03

In context

Varicose Veins

253 studies on the registry are indexed under Varicose Veins; 35 are open to participants now.

This study's enrollment of 58 is below the median of 124 across 79 observational studies indexed under Varicose Veins.

Browse Varicose Veins studies →

Lead sponsor

Hospital Clínico Universitario de Valladolid is the lead sponsor of 21 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with varicose veins undergoing surgery between january and february of 2023 in Valladolid Clinical Hospital

Inclusion criteria

  • patients with reflux in saphenous vein

Exclusion criteria

Exclusion Criteria:

  • no reflux in saphenous vein
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
58 participants (actual)
Patient registry
No

Interventions

  • Proceduresurgery of varicose veins

    including ablation with radiofrequency, phlebectomy and saphenectomy.

06

What researchers measure

Primary outcomes

  1. changes in qol questionarie SF-12 after surgery of varicose veins

    measured in SF-12 score

    Time frame: before and 90 days after surgery

  2. changes in qol questionarie Veines QoL/Sym after surgery of

    measured in Veines Qol/Sym score

    Time frame: before and 90 days after surgery

Secondary outcomes

  1. changes in VCSS after surgery of varicose veins

    measured in VCSS score

    Time frame: before and 90 days after surgery

07

Study locations

1 site
  • Hospital CLínico Universitario de Valladolid
    Valladolid, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06290973
Lead sponsor
Hospital Clínico Universitario de Valladolid
Responsible party
Diana Gutierrez Castillo (PhD, Hospital Clínico Universitario de Valladolid) — Principal investigator
First posted
Mar 4, 2024
Start date
Jan 2, 2023
Primary completion
Feb 28, 2023
Completion
Nov 14, 2023
Last update
Mar 4, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion